• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

Drugs Made In America Acquisition II Corp. (DMII)

Q2-CY2026

Q1-CY2026

Q4-CY2025

Q3-CY2025

Q2-CY2025

Q1-CY2025

Q4-CY2024

Q3-CY2024

Q2-CY2024

Q1-CY2024

Q4-CY2023

Q3-CY2023

Q2-CY2023

Q1-CY2023

Q4-CY2022

Q3-CY2022

Q2-CY2022

Q1-CY2022

Q4-CY2021

Q3-CY2021

Q2-CY2021

Q1-CY2021

Q4-CY2020

Q3-CY2020

Q2-CY2020

Q1-CY2020

Q4-CY2019

Q3-CY2019

Q2-CY2019

Q1-CY2019

Q4-CY2018

Q3-CY2018

Q2-CY2018

Q1-CY2018

Q4-CY2017

Q3-CY2017

Q2-CY2017

Q1-CY2017

Q4-CY2016

Q3-CY2016

Q2-CY2016

Q1-CY2016

Q4-CY2015

Q3-CY2015

Q2-CY2015

Q1-CY2015

Q4-CY2014

Q3-CY2014

Q2-CY2014

Balance Sheet Date

2025-Dec-31

2025-Sep-30

Fiscal Period

Q4-FY2025

Q3-FY2025

Close Price of Common Stock

10.00$

9.97$

9.87$

Market Cap of Common Stock

655,750,000$

653,782,750$

647,225,250$

QoQ%

.30%

1.01%

YoY%

Common Shares Outstanding

63,700,000

13,700,000

15,575,000

14,375,000

14,375,000

14,375,000

14,375,000

QoQ%

(12.04%)

8.35%

.00%

.00%

.00%

YoY%

343.13%

(4.70%)

8.35%

Price to Sales

Price to Earnings

156.61x

156.14x

154.58x

Price to Book

-

-

-

Total Revenue

QoQ%

YoY%

TTM

TTM_QoQ%

TTM_YoY%

Gross Margin

QoQ

YoY

Operating Income

(235,472$)

(155,513$)

QoQ%

(51.42%)

YoY%

TTM

TTM_QoQ%

TTM_YoY%

Operating Margin

QoQ

YoY

Net Income

4,330,608$

(46,158$)

(38,073$)

(59,327$)

QoQ%

9,482.14%

(21.24%)

35.83%

YoY%

TTM

4,187,050$

TTM_QoQ%

TTM_YoY%

Profit Margin

QoQ

YoY

Equity to Common Shareholders

(17,774,827$)

(17,280,989$)

(214,119$)

(176,046$)

(116,719$)

(6,684$)

QoQ

(493,838$)

(17,066,870$)

(38,073$)

(59,327$)

(110,035$)

QoQ%

(2.86%)

(7,970.74%)

(21.63%)

(50.83%)

(1,646.25%)

YoY

(17,658,108$)

(17,274,305$)

YoY%

(15,128.74%)

(258,442.62%)

Dividends Paid

Additional Paid-In Capital QoQ

Treasury Stock

QoQ

Goodwill

QoQ%

YoY%

Other Intangible Assets

QoQ

Amortization of Intangible Assets

Total Assets

504,959,837$

501,005,711$

138,064$

QoQ

3,954,126$

YoY

504,821,773$

Total Liabilities

17,800,864$

18,177,345$

254,783$

QoQ

(376,481$)

YoY

17,546,081$

Current Ratio

.09x

1.32x

.23x

Total Current Assets

26,037$

896,356$

59,615$

QoQ

(870,319$)

Total Current Liabilities

300,864$

677,345$

254,783$

QoQ

(376,481$)

Debt to Asset Ratio

.04x

.04x

1.85x

Long Term Debt

QoQ

YoY

Capital Lease Obligations

Cash and Cash Equivalents

223$

QoQ

YoY

Interest Expenses

Interest Income

4,824,445$

109,355$

Copy Table ✓